2018 Clinic Complication Individual 
Annals of Family Medicine
NOVEMBER 20, 2024
Context In 2018, 63.1% Objective To implement and evaluate a novel multidisciplinary trajectory aimed at improving the treatment of obesity thus preventing multiple health-related complications. Population Studied Patients with obesity enrolled in the Méta-Santé clinic.
PEMBlog
OCTOBER 18, 2024
The condition affects multiple organ systems—muscular, cardiac, and respiratory—leading to a myriad of clinical complications. Once patients become non-ambulatory, they often develop secondary complications like lymphedema, which further complicates their care. 2018 Oct;142(Suppl 2):S72-S81. 2018-0333I.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
GeriPal
MAY 19, 2022
It depends on the clinical situation. I know this is like, we’re talking about math and so that makes it all a little complicated, but think about it this way. But we still, regardless of how you do this calculation have to temper it with clinical judgment. Eric: All right. The old table, 1.5 Eric: I got two questions.
FDA Law Blog
JULY 10, 2023
Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 These AI requests often address complicated scientific scenarios in which a submitter has already provided some information, but FDA is not completely satisfied. Average Number of Industry Days to MDUFA IV Decision 54.69
GeriPal
JUNE 8, 2023
Our last podcast was with Laura Petrillo in 2018 – 5 years ago seems ancient history – though many of the points still apply today (e.g. If in your own work, your clinical work, is this something that you see people struggle with you, you see yourself struggle with? Goldilocks zone). This is Eric Widera. Tamryn: Yes, 100%.
FDA Law Blog
MAY 17, 2022
FDA approved FIRDAPSE in November 2018, with a period of orphan drug exclusivity, for the treatment of Lambert-Eaton Myasthenic Syndrome (“LEMS”) in adult patients. But in May 2019, FDA approved a second amifampridine drug product, Jacobus Pharmaceutical Company, Inc.’s and more likely 15-20.
The Clinical Problem Solvers
FEBRUARY 8, 2023
Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. These narratives have vilified individuals who would benefit from comprehensive, person-centered substance use treatment, rather than incarceration and other adverse harms.
Expert insights. Personalized for you.
130 
Let's personalize your content